Position in NVO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,359,319
-$48,247 QoQ
Shares Held
49,214
-24.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#351
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Guardian Partners Inc. holds $38,343,491 across 11 Drug Manufacturers - General names. NVO ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
81,690 | $20,746,809 | |
| 2 | SNY |
Sanofi
|
181,975 | $7,763,053 | |
| 3 | LLY |
ELI LILLY & Co
|
3,532 | $4,236,387 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
49,214 | $2,359,319 | |
| 5 | NVS |
Novartis AG
|
7,965 | $1,248,274 | |
| 6 | PFE |
Pfizer Inc
|
46,810 | $1,127,184 | |
| 7 | ABBV |
AbbVie Inc.
|
1,785 | $449,177 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,532 | $325,362 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,359,319 | 49,214 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,407,566 | 65,512 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,792,595 | 74,540 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,455,802 | 134,363 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,010,699 | 130,552 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,939,566 | 128,738 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $10,958,173 | 127,391 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||